Antioxidant activity of three extracts of Morus nigra

Phytotherapy Research

Volumn 18, Issue 5, 2004, Pages 365-369

  Naderi, Gholam Ali ^a   Asgary, Seddigheh ^a   Sarraf Zadegan, Nizal ^a   Oroojy, Heshmatallah ^b   Afshin Nia, Farsad ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antioxidant; Glycosylation; Haemolysis; Lipid peroxidation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALCOHOL DERIVATIVE; BIOFLAVONOID; COPPER ION; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN; HYDROGEN PEROXIDE; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; MORUS NIGRA EXTRACT; PLANT EXTRACT; POLYPHENOL; REACTIVE OXYGEN METABOLITE; TERT BUTYL HYDROPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL FREE SYSTEM; CELL MEMBRANE; CONTROLLED STUDY; CROSS LINKING; ERYTHROCYTE; FRUIT; FRUIT JUICE; GLYCOSYLATION; HEMOLYSIS; HUMAN; HUMAN CELL; KIDNEY FUNCTION; LIPID PEROXIDATION; LIVER CELL; MEMBRANE DAMAGE; MORUS NIGRA; MULBERRY; NONHUMAN; OXIDATION REDUCTION REACTION;

ANIMALS; ANTIOXIDANTS; CHOLESTEROL, LDL; ERYTHROCYTES; FRUIT; HEMOLYSIS; HEPATOCYTES; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALONDIALDEHYDE; MORACEAE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; TERT-BUTYLHYDROPEROXIDE;

MORUS NIGRA;

EID: 2942618497     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.1400     Document Type: Article

References (36)

1. Afanas ev IB, Dorozhko AI, Brodskii AV, Kostyuk VA, Potapovitch AI. 1989. Chelating and free radical scavenging mechanisms of inhibitory action of rutin and quercetin in lipid peroxidation. Biochem Pharmacol 38: 1763-1766.
2. Asgary S, Naderi Gh, Sarraf-Zadegan N et al. 1999. Antioxidant effect of flavonoids on hemoglobin glycosylation. Pharm Acta Helv 73: 223-226.
3. Beutlar E. 1989. Glucose-6-phosphate dehydrogenase deficiency. In The Metabolic Basis of Inherited Disease, 6th edn, Scriver CR, Blaudet AL, Sly WS, Valce V (eds). McGraw-Hill: New York.
4. Bursell SE, Clermont AC, Aiello LP, et al. 1999. High-dose vitamin E supplementation normalizes retinal blood flow and creatinine clearance in patients with type I diabetes. Diabetes Care 22: 1245-1251.
5. Butis CA, Ashwood ER. 1994. Measurement of hemoglobin concentration in whole blood. In Clinical Chemistry. WB Saunders Philadelphia, Pennsylvania, 2020-2030.
6. Fluckiger R, Winter Halter KH. 1978. Biochemical and Clinical Aspects of Hemoglobin Abnormalities. Academic Press: New York, 208.
7. Husain SR, Cillard J, Cillaral P. 1987. Hydroxy radical scavenging activity of flavonoids. Phytochemistry 26: 2489-2491.
8. Ishikawa T, Suzukawa M, Ito T et al. 1997. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 66: 261-266.
9. Joyeux M, Rolland A, Fleurentin Mortier F, Dorfam P. 1990. Tert-butyl hydroperoxide-induced injury in isolated rat hepatocytes: A model for studying antihepatotoxic crude drugs. Planta Med 56: 171-174.
10. Kaul N, Sivwski-Iliskovic N, Thomas TP, Hill M, Khaper N, Singal PK. 1995. Probucol improves antioxidant activity and modulates development of diabetic cardiomyopathy. Nutrition 11: 551-554.
11. Keegan A, Walbank H, Cotter MA, Cameron NE. 1995. Chronic vitamin E treatment prevents defective endothelium-dependent relaxation in diabetic rat aorta. Diabetologia 38: 1475-1478.
12. Koga TM, Moro K, Terao J. 1998. Protective effect of a vitamin E analog phosphatidylchromanol, against oxidative hemolysis of human erythrocytes. Lipid 33: 589-599.
13. Liu GT, Zhang TM, Wang B, Wang XW. 1992. Protective action of seven natural phenolic compounds against peroxidative damage to biomembrane. Biochem Pharmacol 43: 147-152.
14. Markham K-R. 1982. Techniques of Flavonoid Identification. Academic Press: London, 16.
15. Momeni T. 1999. Herbal Extract, 1st edn. Shahid Farhad Reza: Tehrar, 44-48.
16. Morel DW, Chisolm GM. 1989. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity. J Lipid Res 30: 1827-1834.
17. Negra-Sulvayre A, Sulvayer R. 1992. Quercetin prevents the cytotoxicity of oxidized LDL on lymphoid cell lines. Free Rad Biol Med 12: 101-106.
18. Niki E. 1987. Antioxidants in relation to lipid peroxidation. Chem Phys lipid 44: 227-253.
19. Ody Mnimh P. 2000. The Complete Guide Medicinal Herbal, 2nd edn.: Dorling Kindersley, London, 92-93.
20. Rakesh PP, Douglas M, Joanne M-U, Hanjoong J, Joseph SB, Victor MDU 1999. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. Free Radical Biol Med 28: 1780-1793.
21. Ratty AK, Dos NP. 1988. Effects of flavonoids on non enzymatic lipid peroxidation: structure-activity relationship. Biochem Med Metab Biol 39: 69-79.
22. Reavenboer B, Kappalle AC, Hamers FPT, van Buren T, Erkelens DW, Gispen WH 1992. Potential use of glutathione for the prevention and treatment of diabetic neuropathy in the streptozotocin-inducted diabetic rat. Diabetologia 35: 813-817.
23. Regnstrom J, Nilsson J, Tornvall P, Landon C, Hamsten A. 1992. Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man. Lancet 339: 1183-1186.
24. Robak J, Duniec Z, Rzadkowsha-Bodalska H, Olechnowicz-Stepein W, Cisowski W. 1986. The effect of some flavonoids on non-enzymatic lipid oxidation and enzymatic oxidation of arachidonic acid. Pol J Pharmacol Pharm 38: 483-491.
25. Rose WM, Creighton MO, Stewart DHPJ, Sanwal M, Trevithick GR. 1982. Modelling cortical cataractogenesis III: In vivo effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol 17: 61-66.
26. Sajithlal GB, Chithra P, Chandrakasam G. 1998. Effect of curcumin on the advanced glycation and cross-linking of collagen in diabetic rats. Biochem Pharmacol 56: 1607-1614.
27. Samuelsson G. 1999. Drugs of Natural Origin, 4th edn. Pharmaceutical Press: Stockholm, 226-227.
28. Southorn PA. 1988. Free radical in medicine. III. Involvement in human disease. Mayo Clin Proc 63: 390-408.
29. Stampfer MJ, Rimm EB. 1995. Epidemiologic evidence for vitamin E in prevention of cardiovascular disease. Am J Clin Nutr 62: 13655-13695.
30. Steinberg D. 1993. Antioxidant vitamins and coronary heart disease. N Engl J Med 328: 1487-1489.
31. Taniguchi M, Aikawa M, Sakagami T. 1981. A simple and effective method for hemolysis with a hypoxanthine. Xanthine oxidase system and alteration of erythrocyte phospholipid composition during the hemolysis J Biochem 89: 795-800.
32. Thomas SR, Neuzil J, Mohr D, Stocker R. 1995. Co-antioxidants make α-tocopherol an efficient antioxidant for low-density lipoprotein. Am J Clin Nutr 62: 1357-1645.
33. Thompson M, Willians CR, Eliot GEP. 1976. Stability of flavonoid complexes of copper (11) and flavonoid antioxidant activity. Anal Chim Acta 85: 575-581.
34. Ursell A. 2000. The Complete Guide Healing Foods: Dorling Kindersley London, 82-83.
35. Vankampen EJ, Zijlstra WG. 1965. Determination of hemoglobin and its derivatives. Adv Clin Chem 8: 141-187.
36. Witztum JL, Steinberg D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792.